Physician profile
Louis E Samuels
NPI 1902886575
$4,178.43
in general payments reported to CMS, 2019-2025
20 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $197 · 2021: $209 · 2022: $264 · 2023: $221 · 2024: $769 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,754.95 | 2019-2025 | Mitris Resilia Mitral Valve |
| Abbott Laboratories | $1,031.15 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, Navitor |
| Atricure, INC. | $245.68 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $218.46 | 2023-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $157.96 | 2019 | |
| Abiomed | $132.91 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $127.10 | 2024 | Xarelto |
| La Jolla Pharmaceutical Company | $90.92 | 2024-2025 | Giapreza |
| Livanova USA, INC. | $79.77 | 2022 | |
| Paladin Technology Solutions | $59.94 | 2024 | |
| Ethicon US, LLC | $47.26 | 2023-2024 | Prolene, Surgicel Nu-Knit, Ethicon |
| Medtronic, INC. | $45.05 | 2024 | Penditure, Corevalve Evolut R |
| Kci USA, INC. | $33.50 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Astrazeneca Pharmaceuticals LP | $30.27 | 2024 | Wainua |
| Merck Sharp & Dohme LLC | $28.07 | 2024 | Verquvo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.14 | 2024 | Preveleak |
| United Therapeutics Corporation | $21.79 | 2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $18.28 | 2025 | Opsumit, Uptravi |
| Alnylam Pharmaceuticals INC. | $17.09 | 2025 | Onpattro |
| Medicomp INC | $14.14 | 2024 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Samuels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.